Changes in spirometry during consecutive admissions for infective pulmonary exacerbations in adolescent and adult

G E Packe1, M E Hodson

  • 1Department of Cystic Fibrosis, Brompton Hospital, London, U.K.

Respiratory Medicine
|January 1, 1992
PubMed

Insights

Cystic fibrosis (CF) patients experience declining lung function (FEV1, FVC) over time. Repeated hospitalizations for CF exacerbations show diminishing returns in lung function improvement with each admission.

Area of Science:

  • Pulmonology
  • Medical Research

Background:

  • Cystic fibrosis (CF) is a genetic disorder affecting multiple organs, primarily the lungs.
  • Pulmonary infective exacerbations are a major cause of morbidity and mortality in CF patients.
  • Repeated hospitalizations are common for managing CF exacerbations.

Purpose of the Study:

  • To analyze changes in spirometry parameters during consecutive admissions for pulmonary infective exacerbations in CF patients.
  • To assess the long-term impact of repeated exacerbation treatments on lung function.
  • To evaluate lung function trends in severe cases requiring transplantation or leading to death.

Main Methods:

  • Retrospective analysis of spirometry data (FEV1, FVC) from 45 CF patients.
  • Inclusion criteria: five or more admissions for pulmonary infective exacerbations.
  • Comparison of lung function changes over the study period and across consecutive admissions.

Main Results:

  • Significant annual decline in FEV1 (-112.1 ml/yr) and FVC (-47.9 ml/yr) observed.
  • Lung function (FEV1, FVC) improved during each admission but with diminishing magnitude over consecutive admissions.
  • Patients who died or underwent transplantation had FEV1 below 800 ml at their last admission, despite treatment.

Conclusions:

  • Consecutive admissions for CF exacerbations are associated with a progressive decline in lung function.
  • The effectiveness of treatment in improving lung function diminishes with repeated exacerbations.
  • Low FEV1 levels at last admission in severe cases indicate poor prognosis despite intensive care.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Physical Assessment of the Respiratory Tract II: Inspection01:27

Physical Assessment of the Respiratory Tract II: Inspection

Physical assessment of the respiratory tract through inspection is a crucial step in understanding the patient's respiratory health. It provides insights into the functioning of the respiratory system, the musculoskeletal structure, and even the patient's nutritional status. This comprehensive approach involves observing several vital aspects: chest configuration, breathing patterns, respiratory rates, skin color, and use of accessory muscles.
Chest Configuration
The chest configuration can...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...